189 related articles for article (PubMed ID: 25011573)
1. Time-averaged albumin predicts the long-term prognosis of IgA nephropathy patients who achieved remission.
Ni Z; Yuan Y; Wang Q; Cao L; Che X; Zhang M; Xie Y; Qi C; Mou S
J Transl Med; 2014 Jul; 12():194. PubMed ID: 25011573
[TBL] [Abstract][Full Text] [Related]
2. Long-term kidney survival analyses in IgA nephropathy patients under steroids therapy: a case control study.
Yuan Y; Wang Q; Ni Z; Che X; Cao L; Shao X; Zhang M; Xie Y; Qi C; Zhou W; Tian L; Mou S
J Transl Med; 2015 Jun; 13():186. PubMed ID: 26048044
[TBL] [Abstract][Full Text] [Related]
3. Clinical and prognostic significance of C1q deposition in IgAN patients-a retrospective study.
Tian S; Yang X; Luo J; Guo H
Int Immunopharmacol; 2020 Nov; 88():106896. PubMed ID: 33182045
[TBL] [Abstract][Full Text] [Related]
4. Association of time-averaged serum uric acid level with clinicopathological information and long-term outcomes in patients with IgA nephropathy.
Weng M; Fu B; Zhuo Y; Lin J; Zou Z; Chen Y; Cui J; Li G; Chen C; Xu Y; Jiang D; Wan J
PeerJ; 2024; 12():e17266. PubMed ID: 38650643
[TBL] [Abstract][Full Text] [Related]
5. Risk factors of progressive IgA nephropathy which progress to end stage renal disease within ten years: a case-control study.
Shu D; Xu F; Su Z; Zhang J; Chen C; Zhang J; Ding X; Lv Y; Lin H; Huang P
BMC Nephrol; 2017 Jan; 18(1):11. PubMed ID: 28061828
[TBL] [Abstract][Full Text] [Related]
6. The predictive value of free thyroxine combined with tubular atrophy/interstitial fibrosis for poor prognosis in patients with IgA nephropathy.
Yang B; Zhou W; Cui L; Tian L; Ni Y; Yang M; Yang Y
Front Endocrinol (Lausanne); 2024; 15():1372824. PubMed ID: 38808109
[TBL] [Abstract][Full Text] [Related]
7. Serum immunoglobulin G provides early risk prediction in immunoglobulin A nephropathy.
Liu D; You J; Liu Y; Tang X; Tan X; Xia M; Wu L; Chen G; He L; Zhu X; Liu H
Int Immunopharmacol; 2019 Jan; 66():13-18. PubMed ID: 30415190
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and outcomes of IgA nephropathy with nephrotic syndrome.
Kim JK; Kim JH; Lee SC; Kang EW; Chang TI; Moon SJ; Yoon SY; Yoo TH; Kang SW; Choi KH; Han DS; Kie JH; Lim BJ; Jeong HJ; Han SH
Clin J Am Soc Nephrol; 2012 Mar; 7(3):427-36. PubMed ID: 22223610
[TBL] [Abstract][Full Text] [Related]
9. Persistent Hematuria and Kidney Disease Progression in IgA Nephropathy: A Cohort Study.
Yu GZ; Guo L; Dong JF; Shi SF; Liu LJ; Wang JW; Sui GL; Zhou XJ; Xing Y; Li HX; Lv JC; Zhang H
Am J Kidney Dis; 2020 Jul; 76(1):90-99. PubMed ID: 32197881
[TBL] [Abstract][Full Text] [Related]
10. Glomerular C4 deposition and glomerulosclerosis predict worse renal outcomes in Chinese patients with IgA nephropathy.
Yang Y; Tang X; Yang Y; Li X; Li L; Huang K; Li Y; Li J; Fu P
Ren Fail; 2020 Nov; 42(1):629-637. PubMed ID: 32660366
[TBL] [Abstract][Full Text] [Related]
11. Time-Averaged Hematuria as a Prognostic Indicator of Renal Outcome in Patients with IgA Nephropathy.
Weng M; Lin J; Chen Y; Zhang X; Zou Z; Chen Y; Cui J; Fu B; Li G; Chen C; Wan J
J Clin Med; 2022 Nov; 11(22):. PubMed ID: 36431262
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological Features to Predict Progression of IgA Nephropathy with Mild Proteinuria.
Chen D; Liu J; Duan S; Chen P; Tang L; Zhang L; Feng Z; Cai G; Wu J; Chen X
Kidney Blood Press Res; 2018; 43(2):318-328. PubMed ID: 29529608
[TBL] [Abstract][Full Text] [Related]
13. A multicenter, prospective, observational study to determine association of mesangial C1q deposition with renal outcomes in IgA nephropathy.
Tan L; Tang Y; Pei G; Zhong Z; Tan J; Zhou L; Wen D; Sheikh-Hamad D; Qin W
Sci Rep; 2021 Mar; 11(1):5467. PubMed ID: 33750830
[TBL] [Abstract][Full Text] [Related]
14. Complete remission within 2 years predicts a good prognosis after methylprednisolone pulse therapy in patients with IgA nephropathy.
Tatematsu M; Yasuda Y; Morita Y; Sakamoto I; Kurata K; Naruse T; Yamamoto R; Tsuboi N; Sato W; Imai E; Matsuo S; Maruyama S
Clin Exp Nephrol; 2012 Dec; 16(6):883-91. PubMed ID: 22618296
[TBL] [Abstract][Full Text] [Related]
15. High serum and urine neutrophil gelatinase-associated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy.
Rhee H; Shin N; Shin MJ; Yang BY; Kim IY; Song SH; Lee DW; Lee SB; Kwak IS; Seong EY
Korean J Intern Med; 2015 May; 30(3):354-61. PubMed ID: 25995666
[TBL] [Abstract][Full Text] [Related]
16. Significance of tonsillectomy combined with steroid pulse therapy for IgA nephropathy with mild proteinuria.
Komatsu H; Sato Y; Miyamoto T; Tamura M; Nakata T; Tomo T; Nishino T; Miyazaki M; Fujimoto S
Clin Exp Nephrol; 2016 Feb; 20(1):94-102. PubMed ID: 26123429
[TBL] [Abstract][Full Text] [Related]
17. Lower serum bilirubin is associated with poor renal outcome in IgA nephropathy patients.
Jiang Z; Tan J; Wang S; Dong L; Han X; Tang Y; Qin W
Int J Med Sci; 2021; 18(13):2964-2970. PubMed ID: 34220324
[No Abstract] [Full Text] [Related]
18. Copeptin, a surrogate marker for arginine vasopressin, is associated with disease severity and progression in IgA nephropathy patients.
Zittema D; van den Brand JA; Bakker SJ; Wetzels JF; Gansevoort RT
Nephrol Dial Transplant; 2017 Jan; 32(suppl_1):i146-i153. PubMed ID: 28057871
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the Haas and the Oxford classifications for prediction of renal outcome in patients with IgA nephropathy.
Park KS; Han SH; Kie JH; Nam KH; Lee MJ; Lim BJ; Kwon YE; Kim YL; An SY; Kim CH; Doh FM; Koo HM; Oh HJ; Kang SW; Choi KH; Jeong HJ; Yoo TH
Hum Pathol; 2014 Feb; 45(2):236-43. PubMed ID: 24439222
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of massive proteinuria in primary IgA nephropathy with and without nephrotic syndrome: a single center cohort study.
Hu Y; Huang Z; Cao Q; Chen B; Xu S; Qiu W; You X; Zhang J; Chen C
Ren Fail; 2023; 45(2):2267138. PubMed ID: 37850851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]